Overview
- In-depth explanations of pro-angiogenesis and anti-angiogenesis targets and their evaluation methods
- Clinical implications of pro-angiogenesis and anti-angiogenesis strategies
- Dedicated chapter on the impact of nanotechnology, stem cells, and biotechnology in angiogenesis control
- Detailed description of thyroid hormone analogues’ physiology and clinical potential
- Discussion of the future in the clinic for controlling angiogenesis
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (16 chapters)
-
Front Matter
-
Pro-angiogenesis Targets and Clinical Implications
-
Front Matter
-
-
Anti-angiogenesis Targets and Clinical Applications
-
Front Matter
-
-
Back Matter
Keywords
About this book
 This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.
Editors and Affiliations
Bibliographic Information
Book Title: Angiogenesis Modulations in Health and Disease
Book Subtitle: Practical Applications of Pro- and Anti-angiogenesis Targets
Editors: Shaker A. Mousa, Paul J. Davis
DOI: https://doi.org/10.1007/978-94-007-6467-5
Publisher: Springer Dordrecht
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media Dordrecht 2013
Hardcover ISBN: 978-94-007-6466-8Published: 25 May 2013
Softcover ISBN: 978-94-017-8515-0Published: 23 June 2015
eBook ISBN: 978-94-007-6467-5Published: 08 July 2014
Edition Number: 1
Number of Pages: X, 206
Topics: Biomedicine general, Neurosciences, Pharmacy, Life Sciences, general, Biotechnology, Cell Biology